Equity (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Equity [Abstract]
Stock compensation expense	$ 91,144		$ 214,594
Options Expired/Forfeited		237,934
Due to Employees		$ 307,950
Options Outstanding, Beginning Balance		2,255,267	2,480,470
Weighted Avg. Exercise Price Outstanding, Beginning Balance		$ 1.46	$ 0.39
Weighted Average Remaining Contractual Term Outstanding		5 years 3 months 21 days	6 years 3 months 10 days
Aggregate Intrinsic Value Outstanding, Beginning Balance		$ 10,247,548	$ 378,111
Options Granted		849,500	481,167
Weighted Avg. Exercise Price Granted		$ 6.12	$ 1.52
Weighted Average Remaining Contractual Term Granted		3 years 3 days	4 years 9 months
Aggregate Intrinsic Value Granted		$ 1,050
Options Exercised/Forfeited		(487,876)	(851,483)
Weighted Avg. Exercise price Excercised/Forfeited		$ 0.23	$ 0.53
Aggregate Intrinsic Value Exercised/Forfeited		$ 1,356,398
Options Outstanding, Ending Balance	2,110,154	2,378,957	2,110,154
Weighted Avg. Exercise Price Outstanding, Ending balance	$ 0.59	$ 2.95	$ 0.59
Weighted Average Remaining Contractual Term Exercisable at end		4 years 5 months 15 days	5 years 8 months 1 day
Aggregate Intrinsic Value Outstanding, at end	$ 3,605,844	$ 3,074,130	$ 3,605,844
Options Exercisable at end	1,156,062	1,340,832	1,156,062
Weighted Avg. Exercise Price Exercisable at end	$ 0.31	$ 1.68	$ 0.31
Weighted Average Remaining Contractual Term Exercisable at end		4 years 4 months 2 days	5 years 10 months 20 days
Aggregate Intrinsic Value Exercisable at end	$ 2,276,254	$ 2,649,122	$ 2,276,254